PubChem lists the cation under CID 950107, while the iodide salt appears separately as NNMTi under CID 66522933, so product documentation should clearly identify the listed chemical form [1], [3]
It is not approved for human or animal use and must not be administered outside controlled in-vitro research environments
5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2]
References to obesity, adipose tissue, mitochondrial function, or glucose-related pathways on this page are provided for laboratory research context only
It is most relevant during GLP-1 use or caloric deficit, when fatigue is part of the picture, or when progress stalls after a clean first month
Do not repurpose research materials for any non-laboratory application